SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc. (NASDAQ: ILMN) is bringing turn-key data analysis solutions to accelerate and facilitate …
Read More »
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), announced today that …
Read More »
SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc. (NASDAQ: ILMN) is bringing turn-key data analysis solutions to accelerate and facilitate …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced additional data on remdesivir, an …
Read More »
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), announced today that …
Read More »
CAMBRIDGE, Mass., July 9, 2020 /PRNewswire/ — Kymera Therapeutics Inc. today announced the company has …
Read More »
HERTFORDSHIRE, England and PITTSBURGH and TOKYO, July 9, 2020 /PRNewswire/ — Mylan N.V. (NASDAQ: MYL) …
Read More »
INGELHEIM, Germany–(BUSINESS WIRE)–Results of a global survey of 1,375 adults aged at least 45 years …
Read More »
TORONTO–(BUSINESS WIRE)–ProteinQure, a leader in computational protein drug discovery, announces a collaboration with the global …
Read More »
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today …
Read More »
SOUTH SAN FRANCISCO, Calif., July 09, 2020 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a …
Read More »
CAMBRIDGE, Mass., July 08, 2020 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced that positive results …
Read More »
SECAUCUS, N.J., July 8, 2020 /PRNewswire/ — A Health Trends™ study from researchers at Quest …
Read More »
CAMBRIDGE, Mass. and TOKYO, July 08, 2020 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai …
Read More »
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed …
Read More »
MONROVIA, Calif. & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company …
Read More »
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foghorn® Therapeutics Inc., a company advancing an unprecedented class of therapeutics targeting the chromatin …
Read More »
LEXINGTON, Mass.–(BUSINESS WIRE)–Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that the U.S. Food and Drug Administration …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
